Source: Eur Respir J 2005; 25: 490-493



Rating:

Share or cite this content

Citations should be made in the following way:
Khalid M., Al Saghir A., Saleemi S., Al Dammas S., Zeitouni M., Al Mobeireek A., Chaudhry N., Sahovic E.. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study. Eur Respir J 2005; 25: 490-493

Member's Comments

No comment yet.

Related content which might interest you: Azithromycin in bronchiolitis obliterans (BO) and BO organizing pneumonia complicating bone marrow transplantation Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Bronchiolitis obliterans following haematopoietic stem cell transplantation Source: Eur Respir J 2007; 29: 1007-1019 Year: 2007 Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004 A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008 A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011 Bronchiolitis obliterans syndrome (BOS) after bone marrow transplantation (BMT) in childhood Source: Eur Respir J 2003; 22: Suppl. 45, 144s Year: 2003 Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation Source: Annual Congress 2011 - General thoracic surgery I Year: 2011 Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous Year: 2008 Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017 Year: 2018 Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation Source: International Congress 2016 – Orphan diseases II Year: 2016 Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003 Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation Source: Eur Respir J 2004; 23: 440-445 Year: 2004 Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004 Post-transplant bronchiolitis obliterans Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=158 Year: 2003 Introduction: new therapeutic approaches to bronchiolitis obliterans Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005 Mycobacterial infection caused by mycobacterium avium in allogenic bone marrow transplant (BMT) recipient with concomittant bronchiolitis obliterans as a manifestation of graft versus host disease (GvHD) Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007 The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007 Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation Source: Eur Respir J 2011; 38: 470-472 Year: 2011 Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment Year: 2014 Does colonization with pseudomonas affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation? Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible? Year: 2006